Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2025 Earnings Call dated Jan. 30, 2026 Corporate Participants: Ryan Crowe — Senior Vice President of Investor Relations &…
Regeneron Pharmaceuticals Inc (REGN) Q2 2025 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q2 2025 Earnings Call dated Aug. 01, 2025 Corporate Participants: Ryan Crowe — Senior Vice President, Investor Relations & Strategic…
Regeneron Pharmaceuticals Inc (REGN) Q3 2025 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q3 2025 Earnings Call dated Oct. 28, 2025 Corporate Participants: Ryan Crowe — Regeneron Pharmaceuticals, Inc. Leonard S. Schleifer —…
AlphaGraphs
Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7%
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite an increase in revenues. Total…
Regeneron Pharmaceuticals Inc (REGN) Q1 2023 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q1 2023 Earnings Call dated May. 04, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations Leonard S. Schleifer — Co-Founder, President and…
Regeneron Pharmaceuticals Inc (REGN) Q4 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations Leonard S. Schleifer — Co-Founder, President and…
Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31%
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged 31% year-over-year to $3.41 billion…
Regeneron Pharmaceuticals Inc (REGN) Q3 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Ryan Crowe — Vice President, Investor Relations Leonard Schleifer — President and Chief Executive Officer…
Regeneron Pharmaceuticals Inc. (REGN) Q2 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q2 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Ryan Crowe — Vice President of Investor Relations Leonard S. Schleifer — Founder, President,…
Regeneron Pharmaceuticals Inc. (REGN) Q1 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Ryan Crowe — Vice President of Investor Relations Leonard Schleifer — President & Chief…